Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, Arsène Mekinian, Zahir Amoura, Patrice Cacoub, Divi Cornec, Eric Hachulla, Pierre Quartier, Isabelle Melki, Christophe Richez, Raphaele Seror, Benjamin Terrier, Valérie Devauchelle-Pensec, Julien Henry, Marc Gatfosse, Laurence Bouillet, Emeline Gaigneux, Vincent Andre, Gildas Baulier, Aurélie Saunier, Marie Desmurs, Antoine Poulet, Mathieu Ete, Boris Bienvenu, Marie-Elise Truchetet, Martin Michaud, Claire Larroche, Azeddine Dellal, Amélie Leurs, Sebastien Ottaviani, Hubert Nielly, Guillaume Vial, Roland Jaussaud, Bénedicte Rouvière, Pierre-Yves Jeandel, Aurelien Guffroy, Anne-Sophie Korganow, Mathieu Jouvray, Alain Meyer, Emmanuel Chatelus, Christelle Sordet, Renaud Felten, Jean Sibilia, Samira Litim-Ahmed-Yahia, Jean-Francois Kleinmann, Xavier Mariette
RMD Open Nov 2022, 8 (2) e002324; DOI: 10.1136/rmdopen-2022-002324
